[HTML][HTML] SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
As the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
expands, genomic epidemiology and whole genome sequencing are being used to investigate …
expands, genomic epidemiology and whole genome sequencing are being used to investigate …
SARS-CoV-2 B. 1.617 mutations L452R and E484Q are not synergistic for antibody evasion
The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020.
There have been fears that 2 key mutations seen in the receptor-binding domain, L452R and …
There have been fears that 2 key mutations seen in the receptor-binding domain, L452R and …
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Delhi, the national capital of India, experienced multiple severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…
[HTML][HTML] Transmission of B. 1.617. 2 Delta variant between vaccinated healthcare workers
…, WL Hamilton, K Kamelian, S Singh, P Rakshit… - Scientific Reports, 2022 - nature.com
Breakthrough infections with SARS-CoV-2 Delta variant have been reported in doubly-vaccinated
recipients and as re-infections. Studies of viral spread within hospital settings have …
recipients and as re-infections. Studies of viral spread within hospital settings have …
[HTML][HTML] SARS-CoV-2 B. 1.617. 2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
The SARS-CoV-2 B. 1.617. 2 (Delta) variant was first identified in the state of Maharashtra in
late 2020 and spread throughout India, outcompeting pre-existing lineages including B. …
late 2020 and spread throughout India, outcompeting pre-existing lineages including B. …
[HTML][HTML] Integrated genomic view of SARS-CoV-2 in India
Background: India first detected SARS-CoV-2, causal agent of COVID-19 in late January
2020, imported from Wuhan, China. From March 2020 onwards, the importation of cases from …
2020, imported from Wuhan, China. From March 2020 onwards, the importation of cases from …
[HTML][HTML] SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
[HTML][HTML] SARS-CoV-2 B. 1.617 emergence and sensitivity to vaccine-elicited antibodies
The B.1.617 variant emerged in the Indian state of Maharashtra in late 2020 and has spread
throughout India and to at least 40 countries. There have been fears that two key mutations …
throughout India and to at least 40 countries. There have been fears that two key mutations …
[HTML][HTML] A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry
In the last few months, there has been a global catastrophic outbreak of severe acute respiratory
syndrome disease caused by the novel coronavirus SARS-CoV-2 affecting millions of …
syndrome disease caused by the novel coronavirus SARS-CoV-2 affecting millions of …
SARS-CoV-2 B. 1.617. 2 Delta variant emergence, replication and sensitivity to neutralising antibodies
The SARS-CoV-2 B.1.617.2 (Delta) variant was first identified in the state of Maharashtra in
late 2020 and spread throughout India, displacing the B.1.1.7 (Alpha) variant and other pre-…
late 2020 and spread throughout India, displacing the B.1.1.7 (Alpha) variant and other pre-…